Archives: Agenda

With a disproportionately large number of patients willing to participate in global studies, Canada’s world-class researchers and diverse patient population, trial cost efficiency, robust health authority with reliable process times, consistent data quality, and national therapeutic expertise in oncology make it an attractive country for enrollment to your global clinical trial program.

This presentation explores how to succeed with your oncology trial in Canada with insights on:

• The Perception Gap
• How Sponsors Receive: Predictability. Speed. Quality. Partner Accountability
• Competitive Structural Advantages
• Real-World Global Trial Examples
• What to Expect in a Partner for the Region

• Tackling challenges in cell therapy study design to reduce timelines and ensure quality and relevance for the field
• Partnering effectively with CROs: what constitutes a productive collaboration in the cell therapy space
• Logistics in cell therapy: challenges and solutions

• Keeping compliant with evolving global, regional, and local regulation to minimize timelines and avoid costly delays
• Overviewing new regulation and assessing the impact on conducting oncology clinical trials
• Ensuring vendor oversight to ensure regulatory compliance for smooth running of oncology clinical trials
• Considering Project Optimus early in development programs to keep in line with regulatory demands

How strategic collaboration can accelerate innovation:

• Moving from transactional execution to consultative partnership
• How CROs can become strategic problem solvers, not just service providers
• Building trust transparency and shared accountability

• Exploring key challenges AI can solve to identify how it can be used to optimize supply chain management
• Understanding what is required to enable AI to ensure successful implementation
• Highlighting the importance of organizational alignment to adopt AI effectively and drive measurable value

• The landscape of clinical trials is undergoing a transformative shift as digital technologies continue to permeate every aspect of the healthcare industry
• One potential transformation could be the replacement of traditional paper-based relabelling in clinical trials with digital display labels
• The integration of digital display labels into clinical trials represents a significant leap forward in the industry. As this technology matures and becomes more widely adopted, it could impact the way clinical trials are conducted and managed especially in the areas of remote monitoring, adaptive trials, and patient engagement
• In this session, we will explore the challenges associated with traditional relabelling processes in clinical trials, the advantages of adopting digital display labels, and the potential impact on the future of healthcare research

• What are AI Teammates, and why do they matter?
• How teammates elevate risk management with proactive detection and smart alerts
• Using agents for greater precision in supply planning with optimized forecasting and demand planning